Skip to main content
PMC home page
Gut logoLink to Gut
. 1992 Mar;33(3):289–292. doi: 10.1136/gut.33.3.289

Helicobacter pylori and peptic ulcers: the present position.

S Moss 1, J Calam 1
PMCID: PMC1373812  PMID: 1568643

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman Z., Karmeli F., Ligumsky M., Rachmilewitz D. Enhanced gastric and duodenal platelet-activating factor and leukotriene generation in duodenal ulcer patients. Scand J Gastroenterol. 1990 Sep;25(9):925–934. doi: 10.3109/00365529008997614. [DOI] [PubMed] [Google Scholar]
  2. Bailey T. M., Schantz P. M. Trends in the incidence and transmission patterns of trichinosis in humans in the United States: comparisons of the periods 1975-1981 and 1982-1986. Rev Infect Dis. 1990 Jan-Feb;12(1):5–11. doi: 10.1093/clinids/12.1.5. [DOI] [PubMed] [Google Scholar]
  3. Bell G. D., Weil J., Harrison G., Morden A., Jones P. H., Gant P. W., Trowell J. E., Yoong A. K., Daneshmend T. K., Logan R. F. 14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet. 1987 Jun 13;1(8546):1367–1368. doi: 10.1016/s0140-6736(87)90664-7. [DOI] [PubMed] [Google Scholar]
  4. Berkowicz J., Lee A. Person-to-person transmission of Campylobacter pylori. Lancet. 1987 Sep 19;2(8560):680–681. doi: 10.1016/s0140-6736(87)92458-5. [DOI] [PubMed] [Google Scholar]
  5. Blair A. J., 3rd, Feldman M., Barnett C., Walsh J. H., Richardson C. T. Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. J Clin Invest. 1987 Feb;79(2):582–587. doi: 10.1172/JCI112850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Calam J., Tracy H. J. Pyloric reflux and G-cell hyperfunction. Lancet. 1980 Oct 25;2(8200):918–918. doi: 10.1016/s0140-6736(80)92077-2. [DOI] [PubMed] [Google Scholar]
  7. Cave D. R., Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet. 1989 Jul 22;2(8656):187–189. doi: 10.1016/s0140-6736(89)90372-3. [DOI] [PubMed] [Google Scholar]
  8. Chiverton S. G., Hunt R. H. Initial therapy and relapse of duodenal ulcer: possible acid secretory mechanisms. Gastroenterology. 1989 Feb;96(2 Pt 2 Suppl):632–639. doi: 10.1016/s0016-5085(89)80059-9. [DOI] [PubMed] [Google Scholar]
  9. Cooper R. G., Dockray G. J., Calam J., Walker R. Acid and gastrin responses during intragastric titration in normal subjects and duodenal ulcer patients with G-cell hyperfunction. Gut. 1985 Mar;26(3):232–236. doi: 10.1136/gut.26.3.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cover T. L., Dooley C. P., Blaser M. J. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun. 1990 Mar;58(3):603–610. doi: 10.1128/iai.58.3.603-610.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Crabtree J. E., Shallcross T. M., Heatley R. V., Wyatt J. I. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut. 1991 Dec;32(12):1473–1477. doi: 10.1136/gut.32.12.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Deltenre M., Glupczynski Y., De Prez C., Nyst J. F., Burette A., Labbé M., Jonas C., DeKoster E. The reliability of urease tests, histology and culture in the diagnosis of Campylobacter pylori infection. Scand J Gastroenterol Suppl. 1989;160:19–24. doi: 10.3109/00365528909091730. [DOI] [PubMed] [Google Scholar]
  13. Denizot Y., Sobhani I., Rambaud J. C., Lewin M., Thomas Y., Benveniste J. Paf-acether synthesis by Helicobacter pylori. Gut. 1990 Nov;31(11):1242–1245. doi: 10.1136/gut.31.11.1242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dooley C. P., Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med. 1988 Jan;108(1):70–79. doi: 10.7326/0003-4819-108-1-70. [DOI] [PubMed] [Google Scholar]
  15. Drumm B., Perez-Perez G. I., Blaser M. J., Sherman P. M. Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med. 1990 Feb 8;322(6):359–363. doi: 10.1056/NEJM199002083220603. [DOI] [PubMed] [Google Scholar]
  16. Engstrand L., Scheynius A., Påhlson C., Grimelius L., Schwan A., Gustavsson S. Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun. 1989 Mar;57(3):827–832. doi: 10.1128/iai.57.3.827-832.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fitzgibbons P. L., Dooley C. P., Cohen H., Appleman M. D. Prevalence of gastric metaplasia, inflammation, and Campylobacter pylori in the duodenum of members of a normal population. Am J Clin Pathol. 1988 Dec;90(6):711–714. doi: 10.1093/ajcp/90.6.711. [DOI] [PubMed] [Google Scholar]
  18. Flejou J. F., Bahame P., Smith A. C., Stockbrugger R. W., Rode J., Price A. B. Pernicious anaemia and Campylobacter like organisms; is the gastric antrum resistant to colonisation? Gut. 1989 Jan;30(1):60–64. doi: 10.1136/gut.30.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fong T. L., Dooley C. P., Dehesa M., Cohen H., Carmel R., Fitzgibbons P. L., Perez-Perez G. I., Blaser M. J. Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology. 1991 Feb;100(2):328–332. doi: 10.1016/0016-5085(91)90199-u. [DOI] [PubMed] [Google Scholar]
  20. Gaskin R. J., Gad A., Barros D'sa A. A., Joffe S. N., Baron J. H. Natural history and morphology of secretagogue-induced duodenal ulcers in rats. Gastroenterology. 1975 Oct;69(4):903–910. [PubMed] [Google Scholar]
  21. Gavey C. J., Szeto M. L., Nwokolo C. U., Sercombe J., Pounder R. E. Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate. Aliment Pharmacol Ther. 1989 Feb;3(1):21–28. doi: 10.1111/j.1365-2036.1989.tb00187.x. [DOI] [PubMed] [Google Scholar]
  22. Gear M. W., Truelove S. C., Whitehead R. Gastric ulcer and gastritis. Gut. 1971 Aug;12(8):639–645. doi: 10.1136/gut.12.8.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Glupczynski Y., Burette A., De Koster E., Nyst J. F., Deltenre M., Cadranel S., Bourdeaux L., De Vos D. Metronidazole resistance in Helicobacter pylori. Lancet. 1990 Apr 21;335(8695):976–977. doi: 10.1016/0140-6736(90)91043-a. [DOI] [PubMed] [Google Scholar]
  24. Glupczynski Y., Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol. 1990 Dec;85(12):1545–1551. [PubMed] [Google Scholar]
  25. Graham D. Y., Klein P. D., Opekun A. R., Boutton T. W. Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis. 1988 Apr;157(4):777–780. doi: 10.1093/infdis/157.4.777. [DOI] [PubMed] [Google Scholar]
  26. Graham D. Y., Opekun A., Lew G. M., Evans D. J., Jr, Klein P. D., Evans D. G. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol. 1990 Apr;85(4):394–398. [PubMed] [Google Scholar]
  27. Hayward R. A., Shapiro M. F., Oye R. K. Laboratory testing on cerebrospinal fluid. A reappraisal. Lancet. 1987 Jan 3;1(8523):1–4. doi: 10.1016/s0140-6736(87)90698-2. [DOI] [PubMed] [Google Scholar]
  28. Kekki M., Sipponen P., Siurala M. Progression of antral and body gastritis in patients with active and healed duodenal ulcer and duodenitis. Scand J Gastroenterol. 1984 May;19(3):382–388. [PubMed] [Google Scholar]
  29. Lam S. K., Koo J. Gastrin sensitivity in duodenal ulcer. Gut. 1985 May;26(5):485–490. doi: 10.1136/gut.26.5.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Langenberg W., Rauws E. A., Oudbier J. H., Tytgat G. N. Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. J Infect Dis. 1990 Mar;161(3):507–511. doi: 10.1093/infdis/161.3.507. [DOI] [PubMed] [Google Scholar]
  31. Leunk R. D., Johnson P. T., David B. C., Kraft W. G., Morgan D. R. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol. 1988 Jun;26(2):93–99. doi: 10.1099/00222615-26-2-93. [DOI] [PubMed] [Google Scholar]
  32. Levi S., Beardshall K., Haddad G., Playford R., Ghosh P., Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet. 1989 May 27;1(8648):1167–1168. doi: 10.1016/s0140-6736(89)92752-9. [DOI] [PubMed] [Google Scholar]
  33. Levi S., Beardshall K., Swift I., Foulkes W., Playford R., Ghosh P., Calam J. Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism. BMJ. 1989 Dec 16;299(6714):1504–1505. doi: 10.1136/bmj.299.6714.1504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mainguet P., Delmée M., Debongnie J. C. Omeprazole, campylobacter pylori, and duodenal ulcer. Lancet. 1989 Aug 12;2(8659):389–390. doi: 10.1016/s0140-6736(89)90569-2. [DOI] [PubMed] [Google Scholar]
  35. Marshall B. J., Goodwin C. S., Warren J. R., Murray R., Blincow E. D., Blackbourn S. J., Phillips M., Waters T. E., Sanderson C. R. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988 Dec 24;2(8626-8627):1437–1442. doi: 10.1016/s0140-6736(88)90929-4. [DOI] [PubMed] [Google Scholar]
  36. Martin D. F., Hollanders D., May S. J., Ravenscroft M. M., Tweedle D. E., Miller J. P. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet. 1981 Jan 3;1(8210):7–10. doi: 10.1016/s0140-6736(81)90114-8. [DOI] [PubMed] [Google Scholar]
  37. McColl K. E., Fullarton G. M., el Nujumi A. M., Macdonald A. M., Brown I. L., Hilditch T. E. Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer. Lancet. 1989 Aug 26;2(8661):499–500. doi: 10.1016/s0140-6736(89)92105-3. [DOI] [PubMed] [Google Scholar]
  38. McNulty C. A., Dent J., Wise R. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother. 1985 Dec;28(6):837–838. doi: 10.1128/aac.28.6.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. McNulty C. A., Gearty J. C., Crump B., Davis M., Donovan I. A., Melikian V., Lister D. M., Wise R. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J (Clin Res Ed) 1986 Sep 13;293(6548):645–649. doi: 10.1136/bmj.293.6548.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Perez-Perez G. I., Dworkin B. M., Chodos J. E., Blaser M. J. Campylobacter pylori antibodies in humans. Ann Intern Med. 1988 Jul 1;109(1):11–17. doi: 10.7326/0003-4819-109-1-11. [DOI] [PubMed] [Google Scholar]
  41. RHODES J. EXPERMENTAL PRODUCTION OF GASTRIC EPITHELIUM IN THE DUODENUM. Gut. 1964 Oct;5:454–458. doi: 10.1136/gut.5.5.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rauws E. A., Langenberg W., Houthoff H. J., Zanen H. C., Tytgat G. N. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. 1988 Jan;94(1):33–40. [PubMed] [Google Scholar]
  43. Rauws E. A., Tytgat G. N. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. 1990 May 26;335(8700):1233–1235. doi: 10.1016/0140-6736(90)91301-p. [DOI] [PubMed] [Google Scholar]
  44. Shames B., Krajden S., Fuksa M., Babida C., Penner J. L. Evidence for the occurrence of the same strain of Campylobacter pylori in the stomach and dental plaque. J Clin Microbiol. 1989 Dec;27(12):2849–2850. doi: 10.1128/jcm.27.12.2849-2850.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sidebotham R. L., Baron J. H. Hypothesis: Helicobacter pylori, urease, mucus, and gastric ulcer. Lancet. 1990 Jan 27;335(8683):193–195. doi: 10.1016/0140-6736(90)90279-e. [DOI] [PubMed] [Google Scholar]
  46. Sjövall M., Lindstedt G., Olbe L., Lundell L. Effect of parietal cell vagotomy and cholinergic blockade on gastrin release in man induced by gastrin-releasing peptide. Digestion. 1990;46(2):114–120. doi: 10.1159/000200340. [DOI] [PubMed] [Google Scholar]
  47. Spychal R. T., Goggin P. M., Marrero J. M., Saverymuttu S. H., Yu C. W., Corbishley C. M., Maxwell J. D., Northfield T. C. Surface hydrophobicity of gastric mucosa in peptic ulcer disease. Relationship to gastritis and Campylobacter pylori infection. Gastroenterology. 1990 May;98(5 Pt 1):1250–1254. doi: 10.1016/0016-5085(90)90341-w. [DOI] [PubMed] [Google Scholar]
  48. Sturgess J. M., Chao J., Wong J., Aspin N., Turner J. A. Cilia with defective radial spokes: a cause of human respiratory disease. N Engl J Med. 1979 Jan 11;300(2):53–56. doi: 10.1056/NEJM197901113000201. [DOI] [PubMed] [Google Scholar]
  49. Tatsuta M., Ishikawa H., Iishi H., Okuda S., Yokota Y. Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime. Gut. 1990 Sep;31(9):973–976. doi: 10.1136/gut.31.9.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  51. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  52. Vaira D., D'Anastasio C., Holton J., Dowsett J. F., Londei M., Bertoni F., Beltrandi E., Grauenfels P., Salmon P. R., Gandolfi L. Campylobacter pylori in abattoir workers: is it a zoonosis? Lancet. 1988 Sep 24;2(8613):725–726. doi: 10.1016/s0140-6736(88)90196-1. [DOI] [PubMed] [Google Scholar]
  53. Weil J., Bell G. D., Jones P. H., Gant P., Trowell J. E., Harrison G. "Eradication" of Campylobacter pylori: are we being misled? Lancet. 1988 Nov 26;2(8622):1245–1245. doi: 10.1016/s0140-6736(88)90827-6. [DOI] [PubMed] [Google Scholar]
  54. Westblom T. U., Duriex D. E. Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Implications for treatment of Helicobacter pylori infections. Dig Dis Sci. 1991 Jan;36(1):25–28. doi: 10.1007/BF01300082. [DOI] [PubMed] [Google Scholar]
  55. Wilson D. R., Honrath U., Sonnenberg H. Effect of acetylcholine and secretin on medullary collecting duct function in the rat. Can J Physiol Pharmacol. 1986 Jan;64(1):62–65. doi: 10.1139/y86-009. [DOI] [PubMed] [Google Scholar]
  56. Wright N. A., Pike C., Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 1990 Jan 4;343(6253):82–85. doi: 10.1038/343082a0. [DOI] [PubMed] [Google Scholar]
  57. Wyatt J. I., Rathbone B. J., Dixon M. F., Heatley R. V. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol. 1987 Aug;40(8):841–848. doi: 10.1136/jcp.40.8.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Xu J. K., Goodwin C. S., Cooper M., Robinson J. Intracellular vacuolization caused by the urease of Helicobacter pylori. J Infect Dis. 1990 Jun;161(6):1302–1304. doi: 10.1093/infdis/161.6.1302. [DOI] [PubMed] [Google Scholar]
  59. Younan F., Pearson J., Allen A., Venables C. Changes in the structure of the mucous gel on the mucosal surface of the stomach in association with peptic ulcer disease. Gastroenterology. 1982 May;82(5 Pt 1):827–831. [PubMed] [Google Scholar]
  60. el Nujumi A. M., Dorrian C. A., Chittajallu R. S., Neithercut W. D., McColl K. E. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut. 1991 Aug;32(8):866–870. doi: 10.1136/gut.32.8.866. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES